Search All UT System Experts

Long-term results of NRG oncology RTOG 0617: Standard-versus high-dose chemoradiotherapy with or without cetuximab for unresectable stage III non-small-cell lung cancer

Jeffrey D. Bradley, Chen Hu, Ritsuko R. Komaki, Gregory A. Masters, George R. Blumenschein, Steven E. Schild, Jeffrey A. Bogart, Kenneth M. Forster, Anthony M. Magliocco, Vivek S. Kavadi, Samir Narayan, Puneeth Iyengar, Clifford G. Robinson, Raymond B. Wynn, Christopher D. Koprowski, Michael R. Olson, Joanne Meng, Rebecca Paulus, Walter J. Curran, Hak Choy

Research output: Contribution to journal › Article › peer-review

323 Scopus citations

Fingerprint

Dive into the research topics of 'Long-term results of NRG oncology RTOG 0617: Standard-versus high-dose chemoradiotherapy with or without cetuximab for unresectable stage III non-small-cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences